当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:521.37亿  总市值:638.70亿
流通股本:12.99亿   总股本:15.91亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金7,031,707,6166,157,937,2536,452,330,0336,032,284,850
  交易性金融资产3,977,200,7673,341,606,7261,815,478,9851,456,758,259
  应收票据及应收账款4,722,865,6154,790,745,0254,943,841,6194,673,225,051
        应收账款4,722,865,6154,790,745,0254,943,841,6194,673,225,051
  应收款项融资775,389,674966,027,5281,289,655,0431,334,186,292
  预付款项740,751,222475,663,958513,862,092431,737,560
  其他应收款合计106,463,35088,671,458122,017,70982,686,774
  其中:应收利息4,862,7324,822,9084,781,8454,730,883
        应收股利0-09,601,877
  存货4,196,771,8453,842,113,2993,792,786,2793,847,311,805
  其他流动资产1,883,633,6172,101,530,8642,354,944,1172,181,828,358
  流动资产合计23,434,783,70621,764,296,11121,284,915,87720,040,018,949
非流动资产:
  长期股权投资4,585,812,3594,557,812,2444,513,161,9514,464,937,200
  其他权益工具投资126,997,125127,791,610129,565,312130,424,617
  其他非流动金融资产58,516,78246,516,78246,516,78228,516,782
  固定资产10,769,559,13710,929,629,74810,972,547,95910,968,762,041
  在建工程1,475,873,4741,426,995,6911,534,160,0021,504,433,047
  使用权资产578,739,490590,130,558591,248,755600,507,032
  无形资产1,165,402,7631,189,816,6381,214,145,8211,226,104,158
  开发支出0--0
  商誉96,249,05696,249,05696,249,05696,249,056
  长期待摊费用84,315,14887,908,48792,061,58090,874,938
  递延所得税资产414,961,847432,441,351452,691,567455,253,463
  其他非流动资产241,023,910237,301,318214,545,548228,742,042
  非流动资产合计19,597,451,09119,722,593,48319,856,894,33319,794,804,376
  资产总计43,032,234,79741,486,889,59441,141,810,21039,834,823,325
流动负债:
  短期借款2,071,232,7552,541,986,4122,418,468,6752,556,965,665
  交易性金融负债0217,382901,1700
  应付票据及应付账款2,852,876,5212,712,226,1162,562,514,3902,532,510,668
  其中:应付票据570,792,828402,406,227239,177,754138,793,857
        应付账款2,282,083,6932,309,819,8892,323,336,6362,393,716,811
  合同负债247,451,996326,434,088490,648,651448,178,109
  应付职工薪酬532,236,687440,541,320353,622,369624,444,529
  应交税费207,411,579210,829,089233,305,751225,358,893
  其他应付款合计1,789,799,3192,276,279,6812,328,550,3981,867,867,373
  其中:应付利息0--0
        应付股利200,394,332--0
  一年内到期的非流动负债1,157,827,7591,165,303,285656,340,614211,875,427
  其他流动负债719,402,726717,161,2861,021,778,076722,427,944
  流动负债合计9,578,239,34210,390,978,65910,066,130,0949,189,628,608
非流动负债:
  长期借款0183,750,000191,100,000191,100,000
  租赁负债527,176,767527,113,049528,297,063544,456,330
  预计负债7,488,3446,105,6215,265,6523,743,023
  递延收益310,496,637316,617,354316,540,410326,806,570
  递延所得税负债235,010,419238,400,347287,631,473285,195,131
  其他非流动负债0--0
  非流动负债合计1,080,172,1671,271,986,3711,328,834,5981,351,301,054
  负债合计10,658,411,50911,662,965,03011,394,964,69210,540,929,662
所有者权益(或股东权益):
  实收资本(或股本)1,590,781,2081,590,781,2081,598,053,3721,598,053,372
  资本公积9,961,206,5808,697,917,5078,794,960,6728,767,986,121
  减:库存股10,367,00010,367,000142,068,777131,701,776
  其他综合收益2,404,98528,570,6956,844,21863,559,610
  专项储备2,872,8972,866,8852,923,2952,826,395
  盈余公积1,743,693,0581,743,693,0581,743,693,0581,743,693,058
  未分配利润12,702,364,99612,563,500,44512,633,754,69212,180,053,980
  归属于母公司股东权益合计25,992,956,72424,616,962,79824,638,160,53024,224,470,760
  少数股东权益6,380,866,5645,206,961,7665,108,684,9885,069,422,903
  股东权益合计32,373,823,28829,823,924,56429,746,845,51829,293,893,663
  负债和股东权益合计43,032,234,79741,486,889,59441,141,810,21039,834,823,325
公告日期2026-10-292026-08-272026-04-292026-04-03
审计意见(境内)标准无保留意见
TOP↑